Autopsy report · NCT00151476
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
Cause of deathNo reason given
“See Detailed Description”
Life of this trial
- Registered 10 months after it had already started.
- Ran for about 4 years before it stopped.
- 68 participants enrolled.
- Results were posted on the registry 1 year 4 months after it ended.
Vital statistics
- Status
- Terminated
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Familial Adenomatous Polyposis (FAP)
- Interventions
- Celecoxib; Routine Medical Care
- Participants
- 68
- Sites
- 4
- Countries
- Canada, Denmark, Spain, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.